TY - JOUR
T1 - An initiative of cooperation in Zika virus research
T2 - the experience of the ZIKABRA study in Brazil
AU - on behalf of ZIKABRA Study Team
AU - Giozza, Silvana Pereira
AU - Bermúdez, Ximena Pamela Díaz
AU - Kara, Edna Oliveira
AU - Calvet, Guilherme Amaral
AU - de Filippis, Ana Maria Bispo
AU - Lacerda, Marcus Vinícius Guimarães
AU - Bôtto-Menezes, Camila Helena Aguiar
AU - da Castilho, Marcia Costa
AU - Franca, Rafael Freitas Oliveira
AU - Neto, Armando Menezes
AU - Storme, Casey
AU - Lima, Noemia S.
AU - Modjarrad, Kayvon
AU - de Oliveira, Maria Cristina Pimenta
AU - Pereira, Gerson Fernando Mendes
AU - Broutet, Nathalie
AU - de Abreu, André Luiz
AU - Bermúdez, Ximena Pamela Díaz
AU - Bôtto-Menezes, Camila Helena Aguiar
AU - Brasil, Patrícia
AU - Brito, Carlos Alexandre Antunes
AU - Broutet, Nathalie Jeanne Nicole
AU - Fernandes, Tatiana Jorge
AU - de Filippis, Ana Maria Bispo
AU - Franca, Rafael Freitas Oliveira
AU - Giozza, Silvana Pereira
AU - Habib, Ndema
AU - Kara, Edna Oliveira
AU - Lacerda, Marcus Vinicius Guimarães
AU - Landoulsi, Sihem
AU - Lima, Morganna Costa
AU - Lima, Noemia
AU - de Mello, Maeve Brito
AU - Meurant, Robyn
AU - Modjarrad, Kayvon
AU - Neto, Armando Menezes
AU - Pereira, Gerson Fernando Mendes
AU - Pimenta, Cristina
AU - Storme, Casey
AU - Ströher, Ute
AU - Thorson, Anna
AU - Trautman, Lydie
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12/1
Y1 - 2021/12/1
N2 - Background: The Zika virus outbreak has triggered a set of local and global actions for a rapid, effective, and timely public health response. A World Health Organization (WHO) initiative, supported by the Department of Chronic Condition Diseases and Sexually Transmitted Infections (DCCI) of the Health Surveillance Secretariat (SVS), Brazil Ministry of Health (MoH) and other public health funders, resulted in the start of the “Study on the persistence of Zika virus in body fluids of patients with ZIKV infection in Brazil – ZIKABRA study”. The ZIKABRA study was designed to increase understanding of how long ZIKV persists in bodily fluids and informing best measures to prevent its transmission. Data collection began in July 2017 and the last follow up visit occurred in 06/26/2020. Methods: A framework for the ZIKABRA Cooperation initiative is provided through a description and analysis of the mechanisms, strategies and the ethos that have guided the models of international governance and technical cooperation in health for scientific exchange in the context of a public health emergency. Among the methodological strategies, we included a review of the legal documents that supported the ZIKABRA Cooperation; weekly documents produced in the meetings and working sessions; technical reports; memorandum of understanding and the research protocol. Conclusion: We highlight the importance of working in cooperation between different institutional actors to achieve more significant results than that obtained by each group working in isolation. In addition, we point out the advantages of training activities, ongoing supervision, the construction of local installed research capacity, training academic and non-academic human resources, improvement of laboratory equipment, knowledge transfer and the availability of the ZIKABRA study protocol for development of similar studies, favoring the collective construction of knowledge to provide public health emergency responses. Strategy harmonization; human resources and health services; timing and recruiting particularities and processing institutional clearance in the different sites can be mentioned as challenges in this type of initiative.
AB - Background: The Zika virus outbreak has triggered a set of local and global actions for a rapid, effective, and timely public health response. A World Health Organization (WHO) initiative, supported by the Department of Chronic Condition Diseases and Sexually Transmitted Infections (DCCI) of the Health Surveillance Secretariat (SVS), Brazil Ministry of Health (MoH) and other public health funders, resulted in the start of the “Study on the persistence of Zika virus in body fluids of patients with ZIKV infection in Brazil – ZIKABRA study”. The ZIKABRA study was designed to increase understanding of how long ZIKV persists in bodily fluids and informing best measures to prevent its transmission. Data collection began in July 2017 and the last follow up visit occurred in 06/26/2020. Methods: A framework for the ZIKABRA Cooperation initiative is provided through a description and analysis of the mechanisms, strategies and the ethos that have guided the models of international governance and technical cooperation in health for scientific exchange in the context of a public health emergency. Among the methodological strategies, we included a review of the legal documents that supported the ZIKABRA Cooperation; weekly documents produced in the meetings and working sessions; technical reports; memorandum of understanding and the research protocol. Conclusion: We highlight the importance of working in cooperation between different institutional actors to achieve more significant results than that obtained by each group working in isolation. In addition, we point out the advantages of training activities, ongoing supervision, the construction of local installed research capacity, training academic and non-academic human resources, improvement of laboratory equipment, knowledge transfer and the availability of the ZIKABRA study protocol for development of similar studies, favoring the collective construction of knowledge to provide public health emergency responses. Strategy harmonization; human resources and health services; timing and recruiting particularities and processing institutional clearance in the different sites can be mentioned as challenges in this type of initiative.
KW - International cooperation in health
KW - Outbreak
KW - Public health emergency
KW - Zika virus
UR - http://www.scopus.com/inward/record.url?scp=85103296207&partnerID=8YFLogxK
U2 - 10.1186/s12889-021-10596-0
DO - 10.1186/s12889-021-10596-0
M3 - Article
C2 - 33757480
AN - SCOPUS:85103296207
SN - 1472-698X
VL - 21
JO - BMC Public Health
JF - BMC Public Health
IS - 1
M1 - 572
ER -